论文部分内容阅读
We retrospectively analyzed allogenic stem cell transplantation (allo-SCT) outcomes in 82 patients with AML or MDS were conditioned with udarabine,idarubicin,intravenous-busulfan and cytarabine (FIBA) or busulfan and cyclophosphamide (BuCy).